Mylan"s Epi-Pen plan

Share this article:
Mylan"s Epi-Pen plan
Mylan"s Epi-Pen plan

Mylan's latest allergy awareness campaign couples two popular touch points—celebrity and access. The Get Schooled in Anaphylaxis campaign features Emmy-winner Julie Bowen and a push to create programs to help schools better understand potentially deadly allergies and how to handle them.

The program includes print and broadcast PSAs plus a financial incentive—Epi-Pen maker Mylan will award 15 college scholarships of $2,000 each for students who submit winning proposals for spreading awareness and providing solutions that could help students suffering from anaphylaxis.

Bowen signed on to the Mylan mission based on personal experience: on the website she shares that her son's allergy took her family by surprise, because one day he was OK eating peanut butter, and the next he wasn't.

The financials behind the push show the company is not relying on past performance. Reports for the quarter ended June 30 show the company increased its marketing costs for the Epi-Pen by $5.3 million for the quarter, compared to the same period last year. It also noted in its 2011 annual report that the device owns 95% of the auto-injector US market and more than 90% of that same market worldwide.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?